Safety and Immunogenicity of the Candidate Vaccine MVA-MERS-S_DF-1 Against MERS

Clinical trial NCT04119440 · COMPLETED

Trial details

NCT number: NCT04119440
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

MERS (Middle East Respiratory Syndrome)

Start date: 2021-04-16
Primary completion: 2022-11-28
Enrollment: 145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.